Effects of mindfulness training on posttraumatic stress symptoms from a community-based pilot clinical trial among survivors of intimate partner violence.

category

rct

is Randomized Controlled Trial

true

basis

After consent and baseline, PCL-5 strata were split at 55; allocation used a prespecified order generated by random-number generator. Concealment not reported.

sources

https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

review Scope

full-text

scope

Paper

status

assessed

score

2

randomized Controlled Trial

true

peer Reviewed

true

blinding

not-confirmed

basis

After consent and baseline, PCL-5 strata were split at 55; allocation used a prespecified order generated by random-number generator. Concealment not reported.

sources

https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

review Scope

full-text

human Approval

false

display Crosses

2

masking Roles

participants

not established from accessed source

providers

not established from accessed source

assessors

not blinded; explicitly acknowledged in limitations

analysts

not established from accessed source

rating Scale

library-trust-factor/1-3

status

unassessed

score

Not recorded

evidence Type

Pilot RCT

intervention

Standard MBSR with trauma-responsive adaptations Eight weekly 120-minute group sessions; results also mention intensive retreat attendance without a clear retreat dose.

comparator

Health-education manual plus eight weekly individual15-minute check-in calls; no specialized breathing, movement or meditation teaching.

sample

19 MBSR/10 control. Available assessments16 at 8 weeks and 17 at 12 weeks; physiological/cognitive analyses used smaller subsets. Registry reports35 actual enrolled, unreconciled.

measurement

PTSD symptoms (PCL-5); Emotion dysregulation (DERS); Heart-rate variability (HRV/RMSSD); Attention (Useful Field of View Test; UFOV); Mindfulness (Five-Facet Mindfulness Questionnaire; FFMQ)

timing

12 weeks (registry endpoint); manuscript also assessed 8 weeks

trial Id

NCT03484390

relationship Note

Survivor-focused mind–body intervention. IPV exposure required, but IPV need not be the index event for current PTSD symptoms.

measured Genes

None recorded

pathways

None recorded

source Access

level

full-text

source URLs

https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

retrieved At

2026-10-30T08:28:43.779847+00:00

outcomes

1. name

   PTSD symptoms (PCL-5)

   result

   No statistically significant between-group effect according to the manuscript narrative and abstract. Within-MBSR improvement does not establish superiority.

   follow Up

   12 weeks (registry endpoint); manuscript also assessed 8 weeks

   effect Estimate

   Within-MBSR Cohen f=.56; not a between-group effect size.

   uncertainty

   The manuscript calls between-group effects nonsignificant but prints contradictory p<.05; no corrected comparative p-value is inferred.

   primary Status

   primary in registry; retrospectively registered

   classification Source

   https://clinicaltrials.gov/api/v2/studies/NCT03484390

   classification Note

   Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

2. name

   Emotion dysregulation (DERS)

   result

   No statistically significant between-group effect according to the manuscript narrative and abstract. Within-MBSR improvement does not establish superiority.

   follow Up

   12 weeks (registry endpoint); manuscript also assessed 8 weeks

   effect Estimate

   Within-MBSR Cohen f=.81; not a between-group effect size.

   uncertainty

   The manuscript calls between-group effects nonsignificant but prints contradictory p<.05; no corrected comparative p-value is inferred.

   primary Status

   secondary in registry; retrospectively registered

   classification Source

   https://clinicaltrials.gov/api/v2/studies/NCT03484390

   classification Note

   Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

3. name

   Heart-rate variability (HRV/RMSSD)

   result

   Reported within-group changes were not statistically significant; no comparative efficacy is established.

   follow Up

   12 weeks (registry endpoint); manuscript also assessed 8 weeks

   effect Estimate

   Not recorded

   uncertainty

   Very small outcome-specific samples and substantial missingness.

   primary Status

   secondary in registry; retrospectively registered

   classification Source

   https://clinicaltrials.gov/api/v2/studies/NCT03484390

   classification Note

   Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

4. name

   Attention (Useful Field of View Test; UFOV)

   result

   Reported divided- and selective-attention changes were not statistically significant; no comparative efficacy is established.

   follow Up

   12 weeks (registry endpoint); manuscript also assessed 8 weeks

   effect Estimate

   Not recorded

   uncertainty

   Very small outcome-specific samples and substantial missingness.

   primary Status

   secondary in registry; retrospectively registered

   classification Source

   https://clinicaltrials.gov/api/v2/studies/NCT03484390

   classification Note

   Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

5. name

   Mindfulness (Five-Facet Mindfulness Questionnaire; FFMQ)

   result

   Registered secondary outcome; no FFMQ results located in the accessed manuscript.

   follow Up

   12 weeks (registry endpoint); manuscript also assessed 8 weeks

   effect Estimate

   Not recorded

   uncertainty

   No FFMQ or Five-Facet mention located outside manuscript references; no effect estimate or result inferred.

   primary Status

   secondary in registry; retrospectively registered

   classification Source

   https://clinicaltrials.gov/api/v2/studies/NCT03484390

   classification Note

   Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

quality

risk Of Bias

High concern from differential missingness, unblinded assessors, unequal contact time/mode and exploratory analyses.

attrition

At8 weeks:7/19 MBSR and 9/10 control; at 12 weeks:8/19 and 9/10. Modified intention-to-treat included available assessments; no complete randomized-denominator estimate established.

confounding

Randomized design, but120-minute group sessions versus 15-minute individual phone calls cannot isolate mindfulness-specific effects.

adverse Findings

No systematic adverse-event totals located. Manuscript anticipates distress or dysregulation during body scan and describes flexible anchoring/adaptations; lack of counts cannot establish safety.

transfer Limits

English-speaking women18–64 with lifetime partner assault and elevated PTSD symptoms; exclusions include active suicidality, recent dependence and major psychiatric/cardiovascular conditions.

jadad

not established

masking Roles

participants

not established from accessed source

providers

not established from accessed source

assessors

not blinded; explicitly acknowledged in limitations

analysts

not established from accessed source

population

relation

direct

population

Adult women survivors

exposure Evidence

Lifetime physical/sexual assault endorsed on LEC-5 and explicitly clarified as perpetrated by an intimate partner.

rationale

Survivor-focused mind–body intervention.

transfer Limit

IPV exposure required, but IPV need not be the index event for current PTSD symptoms.

count

Not recorded

source

Not recorded

retrieved At

Not recorded

status

not-assessed

language

Not recorded

status

approved-for-publication

approved By

Ben Korbel

approved At

2026-11-01

assessment

AI assessed; human approved for publication

scope

Qualified research-library summaries. No professional clinical peer review or treatment recommendation is claimed.

source Revision

audit-r2-596988da2538

source Content Hash

596988da2538e9605b7bd5023afbb193935d14c6e55d18f5333d6077a82da764

level

full-text

source URLs

https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

retrieved At

2026-10-30T08:28:43.779847+00:00

auditor

Codex (AI)

completed At

2026-10-31T05:11:05.655793+00:00

prior Content Hash

0579b45ae10f55be92d4a41656580be98ac3d1156fa6fee5828dd3200424d288

prior Revision

r1-0579b45ae10f

prior Source

frozen-120

source Verification

id

dv-mindbody-32969703

doi

10.1037/tra0000975

pmid

32969703

fresh Metadata

Europe PMC core

metadata Retrieved

true

metadata SHA256

9c241006b5d2d3784ca0afec4ad83b28a31f59b1148ea928c19678667ab6dab8

claim Check

Headline finding/design/limitations compared with indexed abstract or accessible primary evidence; retained methods amendments separately adjudicated.

sources

https://pubmed.ncbi.nlm.nih.gov/32969703/

applied Proposals

methods-mindbody/proposed-fields.json

method

AI editorial assessment of all 130 publication records: compare identity, headline finding, design, relevance and limitations with indexed abstracts or available primary material; adjudicate retained source-supported methods amendments. This is a source-limited publication audit, not an independent full-text systematic review or a clinical guideline.

limitations

Abstract-only records do not establish allocation concealment, complete harms reporting or full risk of bias. · No formal independent RoB 2, GRADE appraisal or numerical reconstruction of every effect was performed. · Source-access labels describe retained appraisal evidence; fuller prior appraisals were checked through their source ledgers and selected material, not independently repeated in full. · Publication counts are not independent trial or participant counts; cohort links and overlapping review evidence remain provisional. · A randomized design cross does not indicate benefit, low risk of bias or human approval. No double-blind trial is verified in this release. · No professional clinical peer review is claimed. Recommended content is limited to accurately qualified research summaries.

mindfulness

https://doi.org/10.1037/tra0000975 · https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

language

Clinical & self-report · Heart rate & autonomic

count

Not recorded

source

Not recorded

retrieved At

Not recorded

status

not-assessed

category

rct

is Randomized Controlled Trial

true

basis

After consent and baseline, PCL-5 strata were split at 55; allocation used a prespecified order generated by random-number generator. Concealment not reported.

sources

https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

review Scope

full-text

scope

Paper

status

assessed

score

2

randomized Controlled Trial

true

peer Reviewed

true

blinding

not-confirmed

basis

After consent and baseline, PCL-5 strata were split at 55; allocation used a prespecified order generated by random-number generator. Concealment not reported.

sources

https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

review Scope

full-text

human Approval

false

display Crosses

2

masking Roles

participants

not established from accessed source

providers

not established from accessed source

assessors

not blinded; explicitly acknowledged in limitations

analysts

not established from accessed source

rating Scale

library-trust-factor/1-3

language

Not recorded

1. key

   language:domestic-family-violence

   title

   Domestic & Family Violence

   collection

   language

   trust Score

   2

1. id

   language-dv-dv-mindbody-32969703

   aliases

   None recorded

   title

   Effects of mindfulness training on posttraumatic stress symptoms from a community-based pilot clinical trial among survivors of intimate partner violence.

   authors

   Gallegos AM; Heffner KL; Cerulli C; Luck P; McGuinness S; Pigeon WR

   year

   2020

   journal

   Psychological trauma : theory, research, practice and policy

   doi

   10.1037/tra0000975

   pmid

   32969703

   urls

   https://doi.org/10.1037/tra0000975 · https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

   collections

   language

   categories

   Clinical & self-report · Heart rate & autonomic

   targets

   None recorded

   neurotransmitters

   None recorded

   conditions

   ptsd · trauma

   condition Evidence

   1. id

      ptsd

      evidence

      1. field

         title

         text

         Effects of mindfulness training on posttraumatic stress symptoms from a community-based pilot clinical trial among survivors of intimate partner violence.

         matched Text

         posttraumatic stress

      2. field

         outcomes

         text

         PTSD symptoms (PCL-5) | Emotion dysregulation (DERS) | Heart-rate variability (HRV/RMSSD) | Attention (Useful Field of View Test; UFOV) | Mindfulness (Five-Facet Mindfulness Questionnaire; FFMQ)

         matched Text

         PTSD

      scope

      Study population or investigated outcome; not a diagnosis or efficacy claim.

   2. id

      trauma

      evidence

      1. field

         title

         text

         Effects of mindfulness training on posttraumatic stress symptoms from a community-based pilot clinical trial among survivors of intimate partner violence.

         matched Text

         posttraumatic

      scope

      Study population or investigated outcome; not a diagnosis or efficacy claim.

   age Groups

   adults

   age Population

   record Id

   dv-mindbody-32969703

   collections

   language

   groups

   adults

   reported Ages

   18–64; mean 42.69 (SD 13.11).

   youth Scope

   Not recorded

   youth Source Note

   No child treatment inference.

   source URL

   https://pubmed.ncbi.nlm.nih.gov/32969703/

   basis Type

   source-limited-ai-editorial-assessment

   classification Note

   Original age terms: adult. Programme targets or possible eligibility are not counted as observed ages.

   community Matches

   1. category Id

      domestic-violence

      relation

      direct

   kind

   Journal article

   design

   Pilot RCT

   origin

   approved-dv-20261101

   priority

   1

   quotes

   None recorded

   finding

   Comparative efficacy remains unproven; fuller methods reveal substantial differential follow-up loss and unequal intervention contact.

   summary

   Comparative efficacy remains unproven; fuller methods reveal substantial differential follow-up loss and unequal intervention contact.

   limitation

   Small pilot, differential missingness, unblinded assessment, unmatched comparator, reporting inconsistencies and retrospective registration.

   evidence

   evidence Type

   Pilot RCT

   intervention

   Standard MBSR with trauma-responsive adaptations Eight weekly 120-minute group sessions; results also mention intensive retreat attendance without a clear retreat dose.

   comparator

   Health-education manual plus eight weekly individual15-minute check-in calls; no specialized breathing, movement or meditation teaching.

   sample

   19 MBSR/10 control. Available assessments16 at 8 weeks and 17 at 12 weeks; physiological/cognitive analyses used smaller subsets. Registry reports35 actual enrolled, unreconciled.

   measurement

   PTSD symptoms (PCL-5); Emotion dysregulation (DERS); Heart-rate variability (HRV/RMSSD); Attention (Useful Field of View Test; UFOV); Mindfulness (Five-Facet Mindfulness Questionnaire; FFMQ)

   timing

   12 weeks (registry endpoint); manuscript also assessed 8 weeks

   trial Id

   NCT03484390

   relationship Note

   Survivor-focused mind–body intervention. IPV exposure required, but IPV need not be the index event for current PTSD symptoms.

   measured Genes

   None recorded

   pathways

   None recorded

   source Access

   level

   full-text

   source URLs

   https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

   retrieved At

   2026-10-30T08:28:43.779847+00:00

   outcomes

   1. name

      PTSD symptoms (PCL-5)

      result

      No statistically significant between-group effect according to the manuscript narrative and abstract. Within-MBSR improvement does not establish superiority.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Within-MBSR Cohen f=.56; not a between-group effect size.

      uncertainty

      The manuscript calls between-group effects nonsignificant but prints contradictory p<.05; no corrected comparative p-value is inferred.

      primary Status

      primary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   2. name

      Emotion dysregulation (DERS)

      result

      No statistically significant between-group effect according to the manuscript narrative and abstract. Within-MBSR improvement does not establish superiority.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Within-MBSR Cohen f=.81; not a between-group effect size.

      uncertainty

      The manuscript calls between-group effects nonsignificant but prints contradictory p<.05; no corrected comparative p-value is inferred.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   3. name

      Heart-rate variability (HRV/RMSSD)

      result

      Reported within-group changes were not statistically significant; no comparative efficacy is established.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Not recorded

      uncertainty

      Very small outcome-specific samples and substantial missingness.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   4. name

      Attention (Useful Field of View Test; UFOV)

      result

      Reported divided- and selective-attention changes were not statistically significant; no comparative efficacy is established.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Not recorded

      uncertainty

      Very small outcome-specific samples and substantial missingness.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   5. name

      Mindfulness (Five-Facet Mindfulness Questionnaire; FFMQ)

      result

      Registered secondary outcome; no FFMQ results located in the accessed manuscript.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Not recorded

      uncertainty

      No FFMQ or Five-Facet mention located outside manuscript references; no effect estimate or result inferred.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   quality

   risk Of Bias

   High concern from differential missingness, unblinded assessors, unequal contact time/mode and exploratory analyses.

   attrition

   At8 weeks:7/19 MBSR and 9/10 control; at 12 weeks:8/19 and 9/10. Modified intention-to-treat included available assessments; no complete randomized-denominator estimate established.

   confounding

   Randomized design, but120-minute group sessions versus 15-minute individual phone calls cannot isolate mindfulness-specific effects.

   adverse Findings

   No systematic adverse-event totals located. Manuscript anticipates distress or dysregulation during body scan and describes flexible anchoring/adaptations; lack of counts cannot establish safety.

   transfer Limits

   English-speaking women18–64 with lifetime partner assault and elevated PTSD symptoms; exclusions include active suicidality, recent dependence and major psychiatric/cardiovascular conditions.

   jadad

   not established

   masking Roles

   participants

   not established from accessed source

   providers

   not established from accessed source

   assessors

   not blinded; explicitly acknowledged in limitations

   analysts

   not established from accessed source

   population

   relation

   direct

   population

   Adult women survivors

   exposure Evidence

   Lifetime physical/sexual assault endorsed on LEC-5 and explicitly clarified as perpetrated by an intimate partner.

   rationale

   Survivor-focused mind–body intervention.

   transfer Limit

   IPV exposure required, but IPV need not be the index event for current PTSD symptoms.

   study Design Assessment

   category

   rct

   is Randomized Controlled Trial

   true

   basis

   After consent and baseline, PCL-5 strata were split at 55; allocation used a prespecified order generated by random-number generator. Concealment not reported.

   sources

   https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

   review Scope

   full-text

   paper Trust Assessment

   scope

   Paper

   status

   assessed

   score

   2

   randomized Controlled Trial

   true

   peer Reviewed

   true

   blinding

   not-confirmed

   basis

   After consent and baseline, PCL-5 strata were split at 55; allocation used a prespecified order generated by random-number generator. Concealment not reported.

   sources

   https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

   review Scope

   full-text

   human Approval

   false

   display Crosses

   2

   masking Roles

   participants

   not established from accessed source

   providers

   not established from accessed source

   assessors

   not blinded; explicitly acknowledged in limitations

   analysts

   not established from accessed source

   rating Scale

   library-trust-factor/1-3

   jadad

   status

   unassessed

   score

   Not recorded

   citation Snapshot

   count

   Not recorded

   source

   Not recorded

   retrieved At

   Not recorded

   status

   not-assessed

   citation Count

   Not recorded

   publication Approval

   status

   approved-for-publication

   approved By

   Ben Korbel

   approved At

   2026-11-01

   assessment

   AI assessed; human approved for publication

   scope

   Qualified research-library summaries. No professional clinical peer review or treatment recommendation is claimed.

   source Revision

   audit-r2-596988da2538

   source Content Hash

   596988da2538e9605b7bd5023afbb193935d14c6e55d18f5333d6077a82da764

   source Access

   level

   full-text

   source URLs

   https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

   retrieved At

   2026-10-30T08:28:43.779847+00:00

   study Family Id

   NCT03484390

   family Linkage Uncertain

   false

   approaches

   mindfulness

   record Id

   dv-mindbody-32969703

   source Pages

   None recorded

   editorial Audit

   auditor

   Codex (AI)

   completed At

   2026-10-31T05:11:05.655793+00:00

   prior Content Hash

   0579b45ae10f55be92d4a41656580be98ac3d1156fa6fee5828dd3200424d288

   prior Revision

   r1-0579b45ae10f

   prior Source

   frozen-120

   source Verification

   id

   dv-mindbody-32969703

   doi

   10.1037/tra0000975

   pmid

   32969703

   fresh Metadata

   Europe PMC core

   metadata Retrieved

   true

   metadata SHA256

   9c241006b5d2d3784ca0afec4ad83b28a31f59b1148ea928c19678667ab6dab8

   claim Check

   Headline finding/design/limitations compared with indexed abstract or accessible primary evidence; retained methods amendments separately adjudicated.

   sources

   https://pubmed.ncbi.nlm.nih.gov/32969703/

   applied Proposals

   methods-mindbody/proposed-fields.json

   method

   AI editorial assessment of all 130 publication records: compare identity, headline finding, design, relevance and limitations with indexed abstracts or available primary material; adjudicate retained source-supported methods amendments. This is a source-limited publication audit, not an independent full-text systematic review or a clinical guideline.

   limitations

   Abstract-only records do not establish allocation concealment, complete harms reporting or full risk of bias. · No formal independent RoB 2, GRADE appraisal or numerical reconstruction of every effect was performed. · Source-access labels describe retained appraisal evidence; fuller prior appraisals were checked through their source ledgers and selected material, not independently repeated in full. · Publication counts are not independent trial or participant counts; cohort links and overlapping review evidence remain provisional. · A randomized design cross does not indicate benefit, low risk of bias or human approval. No double-blind trial is verified in this release. · No professional clinical peer review is claimed. Recommended content is limited to accurately qualified research summaries.

   assessment Record

   id

   dv-mindbody-32969703

   title

   Effects of mindfulness training on posttraumatic stress symptoms from a community-based pilot clinical trial among survivors of intimate partner violence.

   authors

   Gallegos AM · Heffner KL · Cerulli C · Luck P · McGuinness S · Pigeon WR

   year

   2020

   journal

   Psychological trauma : theory, research, practice and policy

   doi

   10.1037/tra0000975

   pmid

   32969703

   trial Registration

   NCT03484390

   collection

   language

   intervention Family

   Mindfulness and meditation

   publication Type

   Primary study

   study Family Id

   NCT03484390

   family Linkage Uncertain

   false

   existing Repository Matches

   None recorded

   relevance

   relation

   direct

   population

   Adult women survivors

   exposure Evidence

   Lifetime physical/sexual assault endorsed on LEC-5 and explicitly clarified as perpetrated by an intimate partner.

   rationale

   Survivor-focused mind–body intervention.

   transfer Limit

   IPV exposure required, but IPV need not be the index event for current PTSD symptoms.

   age

   groups

   adult

   reported Range

   18–64; mean 42.69 (SD 13.11).

   youth Scope

   No child treatment inference.

   country

   United States

   setting

   University of Rochester study recruiting through family court and community domestic violence organizations

   sample Size

   randomized

   29

   analyzed

   Not recorded

   description

   19 MBSR/10 control. Available assessments16 at 8 weeks and 17 at 12 weeks; physiological/cognitive analyses used smaller subsets. Registry reports35 actual enrolled, unreconciled.

   intervention

   description

   Standard MBSR with trauma-responsive adaptations

   dose

   Eight weekly 120-minute group sessions; results also mention intensive retreat attendance without a clear retreat dose.

   provider

   Certified MBSR instructor with additional trauma-informed mindfulness training

   comparator

   Health-education manual plus eight weekly individual15-minute check-in calls; no specialized breathing, movement or meditation teaching.

   outcomes

   1. name

      PTSD symptoms (PCL-5)

      result

      No statistically significant between-group effect according to the manuscript narrative and abstract. Within-MBSR improvement does not establish superiority.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Within-MBSR Cohen f=.56; not a between-group effect size.

      uncertainty

      The manuscript calls between-group effects nonsignificant but prints contradictory p<.05; no corrected comparative p-value is inferred.

      primary Status

      primary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   2. name

      Emotion dysregulation (DERS)

      result

      No statistically significant between-group effect according to the manuscript narrative and abstract. Within-MBSR improvement does not establish superiority.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Within-MBSR Cohen f=.81; not a between-group effect size.

      uncertainty

      The manuscript calls between-group effects nonsignificant but prints contradictory p<.05; no corrected comparative p-value is inferred.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   3. name

      Heart-rate variability (HRV/RMSSD)

      result

      Reported within-group changes were not statistically significant; no comparative efficacy is established.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Not recorded

      uncertainty

      Very small outcome-specific samples and substantial missingness.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   4. name

      Attention (Useful Field of View Test; UFOV)

      result

      Reported divided- and selective-attention changes were not statistically significant; no comparative efficacy is established.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Not recorded

      uncertainty

      Very small outcome-specific samples and substantial missingness.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   5. name

      Mindfulness (Five-Facet Mindfulness Questionnaire; FFMQ)

      result

      Registered secondary outcome; no FFMQ results located in the accessed manuscript.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Not recorded

      uncertainty

      No FFMQ or Five-Facet mention located outside manuscript references; no effect estimate or result inferred.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   finding

   Comparative efficacy remains unproven; fuller methods reveal substantial differential follow-up loss and unequal intervention contact.

   limitation

   Small pilot, differential missingness, unblinded assessment, unmatched comparator, reporting inconsistencies and retrospective registration.

   design

   type

   Pilot RCT

   randomization Evidence

   After consent and baseline, PCL-5 strata were split at 55; allocation used a prespecified order generated by random-number generator. Concealment not reported.

   masking

   participants

   not established from accessed source

   providers

   not established from accessed source

   assessors

   not blinded; explicitly acknowledged in limitations

   analysts

   not established from accessed source

   crosses

   1

   cross Rationale

   Randomization verified in methods. Assessors were not blinded; double blinding is not supported. One cross remains.

   quality

   risk Of Bias

   High concern from differential missingness, unblinded assessors, unequal contact time/mode and exploratory analyses.

   attrition

   At8 weeks:7/19 MBSR and 9/10 control; at 12 weeks:8/19 and 9/10. Modified intention-to-treat included available assessments; no complete randomized-denominator estimate established.

   confounding

   Randomized design, but120-minute group sessions versus 15-minute individual phone calls cannot isolate mindfulness-specific effects.

   adverse Findings

   No systematic adverse-event totals located. Manuscript anticipates distress or dysregulation during body scan and describes flexible anchoring/adaptations; lack of counts cannot establish safety.

   transfer Limits

   English-speaking women18–64 with lifetime partner assault and elevated PTSD symptoms; exclusions include active suicidality, recent dependence and major psychiatric/cardiovascular conditions.

   jadad

   not established

   access

   level

   full-text

   source URLs

   https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

   retrieved At

   2026-10-30T08:28:43.779847+00:00

   sources

   1. url

      https://pubmed.ncbi.nlm.nih.gov/32969703/

      type

      primary publication or PubMed record

      retrieved At

      2026-10-30T07:30:54.246430+00:00

      identity Verified

      true

      notes

      Bibliographic identity and stated extraction checked.

   2. url

      https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode

      type

      NCBI PMC author manuscript through public BioC API

      retrieved At

      2026-10-30T08:28:43.779847+00:00

      identity Verified

      true

      notes

      full-text with machine-readable tables; CONSORT image not inspected; New public API route; manuscript DOI and PMID verified.

   3. url

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      type

      ClinicalTrials.gov official registry API

      retrieved At

      2026-10-30T08:28:43.779847+00:00

      identity Verified

      true

      notes

      complete returned registry record; No results posted; use publication for results.

   publication Status

   status

   published

   correction Retraction Check

   Accessed primary/index record; no systematic retraction-database audit.

   uncertainty

   Publication status may change.

   recommendation Rationale

   Relevant candidate for human appraisal; evidence strength and access limits remain explicit.

   review

   status

   pending

   reviewer

   Not recorded

   assessment Status

   assessed

   assessment Notes

   Primary null finding is retained prominently. · Registry first posted 2018-03-30, after actual start 2016-08-15; final registry enrollment 35 differs from publication 29. No registry results posted. · Table2 provides7/19 and 8/19 MBSR follow-up versus 9/10 controls at each time. Satisfaction findings are limited to seven MBSR post-treatment respondents. · The manuscript labels comparative effects nonsignificant but prints contradictory p<.05. Preserve null conclusion and uncertainty; no invented corrected values. · No new enrolled participants or study family added. · Outcome hierarchy discrepancy: the manuscript Method/Design paragraph broadly describes emotion regulation, attention, physiological stress and PTS as primary outcomes. The retained official registry instead lists PCL-5 as the sole primary outcome at 12 weeks and DERS, HRV, UFOV and FFMQ as secondary at 12 weeks. Proposed primaryStatus labels follow the registry and explicitly retain this discrepancy. · The registration was first posted 2018-03-30 after actual study start 2016-08-15 and before recorded primary completion 2018-05-31. Registry outcome labels therefore do not establish prospective prespecification. · FFMQ appears among registry secondary outcomes, but no FFMQ result was found in the accessed manuscript; absence is recorded without inventing a result.

   research Lane

   mindbody

   review Ready

   true

   review Readiness

   ai-editorial-audit-complete-release-pending

   later Review Evidence

   id

   dv-mindbody-32969703

   title

   Effects of mindfulness training on posttraumatic stress symptoms from a community-based pilot clinical trial among survivors of intimate partner violence.

   prior Revision

   r1-0579b45ae10f

   prior Content Hash

   0579b45ae10f55be92d4a41656580be98ac3d1156fa6fee5828dd3200424d288

   original

   review Ready

   true

   review Readiness

   ready-with-access-limits

   finding

   A null comparative pilot despite favourable within-group changes.

   limitation

   Small, unequal allocation; abstract-only appraisal.

   adverse Findings

   Adverse-event reporting not established; absence of reporting is not evidence of safety.

   crosses

   1

   access

   abstract

   action

   supplement

   hold Current Revision

   false

   cross Verification On Hold

   false

   new Evidence

   Full methods identify 29 randomized participants (19/10), unblinded assessors, unequal contact time and marked differential follow-up. The registry lists 35. A printed p-value conflicts with the narrative description of nonsignificance.

   revised Interpretation

   Retain the null comparative pilot interpretation. Do not substitute favorable within-group change or resolve disputed statistics by inference.

   required Before Approval

   No new hold on the conservative null finding. Reconcile registry enrolment and statistical text before making stronger or precise quantitative claims.

   source URLs

   https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/study/NCT03484390

   source Location

   Methods, Results and registry outcomes/enrolment

   assessment Changed

   false

   human Approval

   false

   publication Recommendation

   status

   recommended-summary

   reason

   Suitable as a qualified research-library summary at the stated source-access level. This is not a conclusion that the intervention is effective or safe.

   scope

   Research summary only; no treatment recommendation

   human Release Approval

   false

   editorial Audit

   auditor

   Codex (AI)

   completed At

   2026-10-31T05:11:05.655793+00:00

   prior Content Hash

   0579b45ae10f55be92d4a41656580be98ac3d1156fa6fee5828dd3200424d288

   prior Revision

   r1-0579b45ae10f

   prior Source

   frozen-120

   source Verification

   id

   dv-mindbody-32969703

   doi

   10.1037/tra0000975

   pmid

   32969703

   fresh Metadata

   Europe PMC core

   metadata Retrieved

   true

   metadata SHA256

   9c241006b5d2d3784ca0afec4ad83b28a31f59b1148ea928c19678667ab6dab8

   claim Check

   Headline finding/design/limitations compared with indexed abstract or accessible primary evidence; retained methods amendments separately adjudicated.

   sources

   https://pubmed.ncbi.nlm.nih.gov/32969703/

   applied Proposals

   methods-mindbody/proposed-fields.json

   method

   AI editorial assessment of all 130 publication records: compare identity, headline finding, design, relevance and limitations with indexed abstracts or available primary material; adjudicate retained source-supported methods amendments. This is a source-limited publication audit, not an independent full-text systematic review or a clinical guideline.

   limitations

   Abstract-only records do not establish allocation concealment, complete harms reporting or full risk of bias. · No formal independent RoB 2, GRADE appraisal or numerical reconstruction of every effect was performed. · Source-access labels describe retained appraisal evidence; fuller prior appraisals were checked through their source ledgers and selected material, not independently repeated in full. · Publication counts are not independent trial or participant counts; cohort links and overlapping review evidence remain provisional. · A randomized design cross does not indicate benefit, low risk of bias or human approval. No double-blind trial is verified in this release. · No professional clinical peer review is claimed. Recommended content is limited to accurately qualified research summaries.

   study Design Assessment

   category

   rct

   is Randomized Controlled Trial

   true

   basis

   After consent and baseline, PCL-5 strata were split at 55; allocation used a prespecified order generated by random-number generator. Concealment not reported.

   sources

   https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

   review Scope

   full-text

   paper Trust Assessment

   scope

   Paper

   status

   assessed

   score

   2

   randomized Controlled Trial

   true

   peer Reviewed

   true

   blinding

   not-confirmed

   basis

   Randomization verified in methods. Assessors were not blinded; double blinding is not supported. One cross remains.

   sources

   https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

   review Scope

   full-text

   human Approval

   false

   display Crosses

   1

   masking Roles

   participants

   not established from accessed source

   providers

   not established from accessed source

   assessors

   not blinded; explicitly acknowledged in limitations

   analysts

   not established from accessed source

   jadad

   status

   unassessed

   score

   Not recorded

   evidence

   population

   relation

   direct

   population

   Adult women survivors

   exposure Evidence

   Lifetime physical/sexual assault endorsed on LEC-5 and explicitly clarified as perpetrated by an intimate partner.

   rationale

   Survivor-focused mind–body intervention.

   transfer Limit

   IPV exposure required, but IPV need not be the index event for current PTSD symptoms.

   intervention

   description

   Standard MBSR with trauma-responsive adaptations

   dose

   Eight weekly 120-minute group sessions; results also mention intensive retreat attendance without a clear retreat dose.

   provider

   Certified MBSR instructor with additional trauma-informed mindfulness training

   comparator

   Health-education manual plus eight weekly individual15-minute check-in calls; no specialized breathing, movement or meditation teaching.

   outcomes

   1. name

      PTSD symptoms (PCL-5)

      result

      No statistically significant between-group effect according to the manuscript narrative and abstract. Within-MBSR improvement does not establish superiority.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Within-MBSR Cohen f=.56; not a between-group effect size.

      uncertainty

      The manuscript calls between-group effects nonsignificant but prints contradictory p<.05; no corrected comparative p-value is inferred.

      primary Status

      primary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   2. name

      Emotion dysregulation (DERS)

      result

      No statistically significant between-group effect according to the manuscript narrative and abstract. Within-MBSR improvement does not establish superiority.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Within-MBSR Cohen f=.81; not a between-group effect size.

      uncertainty

      The manuscript calls between-group effects nonsignificant but prints contradictory p<.05; no corrected comparative p-value is inferred.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   3. name

      Heart-rate variability (HRV/RMSSD)

      result

      Reported within-group changes were not statistically significant; no comparative efficacy is established.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Not recorded

      uncertainty

      Very small outcome-specific samples and substantial missingness.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   4. name

      Attention (Useful Field of View Test; UFOV)

      result

      Reported divided- and selective-attention changes were not statistically significant; no comparative efficacy is established.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Not recorded

      uncertainty

      Very small outcome-specific samples and substantial missingness.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   5. name

      Mindfulness (Five-Facet Mindfulness Questionnaire; FFMQ)

      result

      Registered secondary outcome; no FFMQ results located in the accessed manuscript.

      follow Up

      12 weeks (registry endpoint); manuscript also assessed 8 weeks

      effect Estimate

      Not recorded

      uncertainty

      No FFMQ or Five-Facet mention located outside manuscript references; no effect estimate or result inferred.

      primary Status

      secondary in registry; retrospectively registered

      classification Source

      https://clinicaltrials.gov/api/v2/studies/NCT03484390

      classification Note

      Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

   access

   level

   full-text

   source URLs

   https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

   retrieved At

   2026-10-30T08:28:43.779847+00:00

   citation Snapshot

   count

   Not recorded

   source

   Not recorded

   retrieved At

   Not recorded

   status

   not-assessed

   provenance

   Discovered by AI

   content Hash

   596988da2538e9605b7bd5023afbb193935d14c6e55d18f5333d6077a82da764

   revision

   audit-r2-596988da2538

   archive Entries

   None recorded

   collection

   language

   chapter Number

   5

   topic Id

   domestic-family-violence

   topic Title

   Domestic & Family Violence

   trust Score

   2

evidence Type

Pilot RCT

intervention

Standard MBSR with trauma-responsive adaptations Eight weekly 120-minute group sessions; results also mention intensive retreat attendance without a clear retreat dose.

comparator

Health-education manual plus eight weekly individual15-minute check-in calls; no specialized breathing, movement or meditation teaching.

sample

19 MBSR/10 control. Available assessments16 at 8 weeks and 17 at 12 weeks; physiological/cognitive analyses used smaller subsets. Registry reports35 actual enrolled, unreconciled.

measurement

PTSD symptoms (PCL-5); Emotion dysregulation (DERS); Heart-rate variability (HRV/RMSSD); Attention (Useful Field of View Test; UFOV); Mindfulness (Five-Facet Mindfulness Questionnaire; FFMQ)

timing

12 weeks (registry endpoint); manuscript also assessed 8 weeks

trial Id

NCT03484390

relationship Note

Survivor-focused mind–body intervention. IPV exposure required, but IPV need not be the index event for current PTSD symptoms.

measured Genes

None recorded

pathways

None recorded

source Access

level

full-text

source URLs

https://pubmed.ncbi.nlm.nih.gov/32969703/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8052636/unicode · https://clinicaltrials.gov/api/v2/studies/NCT03484390

retrieved At

2026-10-30T08:28:43.779847+00:00

outcomes

1. name

   PTSD symptoms (PCL-5)

   result

   No statistically significant between-group effect according to the manuscript narrative and abstract. Within-MBSR improvement does not establish superiority.

   follow Up

   12 weeks (registry endpoint); manuscript also assessed 8 weeks

   effect Estimate

   Within-MBSR Cohen f=.56; not a between-group effect size.

   uncertainty

   The manuscript calls between-group effects nonsignificant but prints contradictory p<.05; no corrected comparative p-value is inferred.

   primary Status

   primary in registry; retrospectively registered

   classification Source

   https://clinicaltrials.gov/api/v2/studies/NCT03484390

   classification Note

   Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

2. name

   Emotion dysregulation (DERS)

   result

   No statistically significant between-group effect according to the manuscript narrative and abstract. Within-MBSR improvement does not establish superiority.

   follow Up

   12 weeks (registry endpoint); manuscript also assessed 8 weeks

   effect Estimate

   Within-MBSR Cohen f=.81; not a between-group effect size.

   uncertainty

   The manuscript calls between-group effects nonsignificant but prints contradictory p<.05; no corrected comparative p-value is inferred.

   primary Status

   secondary in registry; retrospectively registered

   classification Source

   https://clinicaltrials.gov/api/v2/studies/NCT03484390

   classification Note

   Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

3. name

   Heart-rate variability (HRV/RMSSD)

   result

   Reported within-group changes were not statistically significant; no comparative efficacy is established.

   follow Up

   12 weeks (registry endpoint); manuscript also assessed 8 weeks

   effect Estimate

   Not recorded

   uncertainty

   Very small outcome-specific samples and substantial missingness.

   primary Status

   secondary in registry; retrospectively registered

   classification Source

   https://clinicaltrials.gov/api/v2/studies/NCT03484390

   classification Note

   Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

4. name

   Attention (Useful Field of View Test; UFOV)

   result

   Reported divided- and selective-attention changes were not statistically significant; no comparative efficacy is established.

   follow Up

   12 weeks (registry endpoint); manuscript also assessed 8 weeks

   effect Estimate

   Not recorded

   uncertainty

   Very small outcome-specific samples and substantial missingness.

   primary Status

   secondary in registry; retrospectively registered

   classification Source

   https://clinicaltrials.gov/api/v2/studies/NCT03484390

   classification Note

   Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

5. name

   Mindfulness (Five-Facet Mindfulness Questionnaire; FFMQ)

   result

   Registered secondary outcome; no FFMQ results located in the accessed manuscript.

   follow Up

   12 weeks (registry endpoint); manuscript also assessed 8 weeks

   effect Estimate

   Not recorded

   uncertainty

   No FFMQ or Five-Facet mention located outside manuscript references; no effect estimate or result inferred.

   primary Status

   secondary in registry; retrospectively registered

   classification Source

   https://clinicaltrials.gov/api/v2/studies/NCT03484390

   classification Note

   Classification follows the retained official registry, first posted 2018-03-30 after study start 2016-08-15; this is retrospective registration, not verified prospective prespecification.

quality

risk Of Bias

High concern from differential missingness, unblinded assessors, unequal contact time/mode and exploratory analyses.

attrition

At8 weeks:7/19 MBSR and 9/10 control; at 12 weeks:8/19 and 9/10. Modified intention-to-treat included available assessments; no complete randomized-denominator estimate established.

confounding

Randomized design, but120-minute group sessions versus 15-minute individual phone calls cannot isolate mindfulness-specific effects.

adverse Findings

No systematic adverse-event totals located. Manuscript anticipates distress or dysregulation during body scan and describes flexible anchoring/adaptations; lack of counts cannot establish safety.

transfer Limits

English-speaking women18–64 with lifetime partner assault and elevated PTSD symptoms; exclusions include active suicidality, recent dependence and major psychiatric/cardiovascular conditions.

jadad

not established

masking Roles

participants

not established from accessed source

providers

not established from accessed source

assessors

not blinded; explicitly acknowledged in limitations

analysts

not established from accessed source

population

relation

direct

population

Adult women survivors

exposure Evidence

Lifetime physical/sexual assault endorsed on LEC-5 and explicitly clarified as perpetrated by an intimate partner.

rationale

Survivor-focused mind–body intervention.

transfer Limit

IPV exposure required, but IPV need not be the index event for current PTSD symptoms.

status

unassessed

score

Not recorded

1. id

   ptsd

   evidence

   1. field

      title

      text

      Effects of mindfulness training on posttraumatic stress symptoms from a community-based pilot clinical trial among survivors of intimate partner violence.

      matched Text

      posttraumatic stress

   2. field

      outcomes

      text

      PTSD symptoms (PCL-5) | Emotion dysregulation (DERS) | Heart-rate variability (HRV/RMSSD) | Attention (Useful Field of View Test; UFOV) | Mindfulness (Five-Facet Mindfulness Questionnaire; FFMQ)

      matched Text

      PTSD

   scope

   Study population or investigated outcome; not a diagnosis or efficacy claim.

2. id

   trauma

   evidence

   1. field

      title

      text

      Effects of mindfulness training on posttraumatic stress symptoms from a community-based pilot clinical trial among survivors of intimate partner violence.

      matched Text

      posttraumatic

   scope

   Study population or investigated outcome; not a diagnosis or efficacy claim.

ptsd · trauma

2

status

not-indexed

retrieval Available

false